Document is current
Any future updates will be listed below
-
Authors
Schweizer, Júnia R.O.L. https://orcid.org/0000-0002-8050-9127
Schilbach, Katharina https://orcid.org/0000-0002-8667-0296
- License Information
-
More Information
Article History
Received: 3 January 2026
Accepted: 5 February 2026
First Online: 15 March 2026
Declarations
:
: Conflict of interest: KS received speaker’s honoraria and consulting fees by from Novo Nordisk, Pfizer, Recordati Rare Disease, Ipsen, Crinetics, Ascendis Pharma, Camurus, and Pharmanovia. Not related to the manuscript.
